中医药联合小剂量靶向药治疗骶尾部脊索瘤1例  

Traditional Chinese medicine combined with low-dose anlotinib therapy for chordoma: A case report

作　　者：赵娜[1,2] 裴晓华 杨宇飞 Zhao Na;Pei Xiaohua;Yang Yufei(Beijing University of Chinese Medicine,Beijing 100029;Xi yuan Hospital,China Academy of Chinese Medical Sciences;Fang shan Hospital of Beijing University of Chinese Medicine)

机构地区：[1]北京中医药大学,北京100029 [2]中国中医科学院西苑医院 [3]北京中医药大学厦门医院

出　　处：《现代中医临床》2021年第3期73-76,共4页Modern Chinese Clinical Medicine

基　　金：国家中医药管理局中医药传承与创新“百千万”人才工程(岐黄工程)岐黄学者项目。

摘　　要：脊索瘤是一种罕见的骨肿瘤亚型,广泛切除加放疗是主要治疗手段。脊索瘤的全身治疗尚缺乏明确有效的强烈推荐药物,可以尝试靶向治疗。中国中医科学院西苑医院杨宇飞教授在脏腑本虚与肿瘤标实辨证基础上,准确把握肿瘤发展不同阶段,针对肿瘤、临床症状、靶向治疗副反应、转移部位全方位考虑,靶向药作为中医辨证后的抗肿瘤手段之一,中西医并重治疗脊索瘤,临床收效满意,附验案一则。Chordoma is a rare subtype of bone cancer. Wide resection with negative surgical margins and radiotherapy are the main effective treatment methods. Although there is no preferred regimen for chordoma, the targeted therapy can still be recommended. On the basis of traditional Chinese medicine(TCM) syndrome differentiation and treatment, Professor Yang Yufei combines TCM treatment with the low-dose targeted therapy to achieve PFS for 12 months in a chordoma case. This article may help inherit valuable experience of TCM experts and take advantage of TCM in the clinical practice for chordoma.

关 键 词：脊索瘤 辨证论治 中医治疗 靶向治疗 

分 类 号：R273[医药卫生—中西医结合]